Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression.
about
A Review of Longitudinal Electroconvulsive Therapy: Neuroimaging InvestigationsCreatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disordersMagnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literatureA brief history of the development of antidepressant drugs: from monoamines to glutamateUse of proton magnetic resonance spectroscopy in the treatment of psychiatric disorders: a critical update.Glutamate and its receptors in the pathophysiology and treatment of major depressive disorderMolecular imaging for depressive disorders.A MRS study of metabolic alterations in the frontal white matter of major depressive disorder patients with the treatment of SSRIsInflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications.Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging studyLack of effect of citalopram on magnetic resonance spectroscopy measures of glutamate and glutamine in frontal cortex of healthy volunteers.Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in ratsBiological substrates underpinning diagnosis of major depression.Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.Decreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder.Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disordersReduced medial prefrontal N-acetyl-aspartate levels in pediatric major depressive disorder: a multi-voxel in vivo(1)H spectroscopy studyGeriatric depression and cognitive impairment.Disturbance of the glutamatergic system in mood disorders.Proton magnetic resonance spectroscopy in depressionStudy protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study).Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy.Blockade of astrocytic glutamate uptake in the prefrontal cortex induces anhedoniaRiluzole effect on occipital cortex: a structural and spectroscopy pilot study.Cognitive dysfunction in elderly females with depressive symptoms.Assessing the effects of electroconvulsive therapy on cortical excitability by means of transcranial magnetic stimulation and electroencephalographyGlutamine deficiency in the prefrontal cortex increases depressive-like behaviours in male miceEvaluating metabolites in patients with major depressive disorder who received mindfulness-based cognitive therapy and healthy controls using short echo MRSI at 7 TeslaElevated levels of NR2A and PSD-95 in the lateral amygdala in depression.Neurochemical metabolites in prefrontal cortex in patients with mild/moderate levels in first-episode depression.Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depressionBiochemical abnormalities of the medial temporal lobe and medial prefrontal cortex in late-life depressionAn Exploratory Study of Spectroscopic Glutamatergic Correlates of Cortical Excitability in Depressed Adolescents.Ketamine as antidepressant? Current state and future perspectives.Corticotropin-releasing hormone, glutamate, and γ-aminobutyric acid in depression.Discovering imaging endophenotypes for major depression.Specific hippocampal choline decrease in an animal model of depression.Chronic pain causes a persistent anxiety state leading to increased ethanol intake in CD1 mice.How Electroconvulsive Therapy Works?: Understanding the Neurobiological Mechanisms.
P2860
Q22299257-E64EA464-A6FC-42A0-9DA9-ED610181B0DCQ24631151-301B1640-7817-41AA-A8C4-68D93209BC2DQ24632936-C11C73D4-1330-4333-94B1-6374D2A1DE7FQ27026039-DD1E3C52-40A9-4EDC-929E-BC4D0B03AFB4Q27028050-B81598E6-C4FF-4458-B27E-F07AE40CEBBEQ30686416-30075332-6A1A-4E27-A444-C601EF76ACCEQ30711088-88E0F1BA-F373-4B6F-82D5-C890285A8051Q30821361-CFEEDFC3-950D-4BD8-AE22-6E5CA6E9AA18Q30942265-79AAEEF1-4072-4FC6-83FE-DC66E24DB1A1Q31141746-DEFA5588-33B7-452D-81D9-E360E670C5DEQ33707664-87A03690-6775-45C7-B36E-5B35B563F933Q33738620-02E334F5-6433-42D7-BE13-530946745226Q33771249-6271EAB2-0D26-47F4-AAFC-968457808570Q33820463-22DEAF99-DC85-48D9-A0B8-2DC88A2FB9A0Q33874459-5EA209E7-5693-47C0-9FFB-8FB6DF144E6EQ34181837-9241EB5D-7E9C-4161-B779-64348594BBCBQ34204211-5C0CEF2C-8EA8-407F-8BCF-3AA0B2A0BF8CQ34238730-8F67D676-6BF0-41CC-ACB8-F510B4A10452Q34641123-7DDA3973-FD9A-42B6-8E5C-32DE2D576C2DQ35149888-48079A21-D0E1-4D38-8F79-261B3FE25FE8Q35702054-6FFBBDD4-4C11-48BC-BC20-D1B1B5E5A0C3Q35816486-3E88CE0E-ACC8-45AE-873A-22F5C29ACCB4Q35930407-402F93AA-9A78-4DBF-990C-6144E9870EADQ36234249-5F828953-F460-44FD-B9E2-680E5CDFFCC2Q36374329-69422243-B87D-4B6C-A639-1E34FCB8CCF2Q36577600-950579AE-2F6F-4C16-A479-1D9A52B1ECB0Q36654980-9142B401-85E0-4021-A5C8-8DEE423453C4Q36788384-D997A9E4-EAF7-4FA5-8A9B-FA52613716CEQ36963961-96553886-8FBC-46DD-ADF2-1041E36F2837Q37104018-22167653-A9E2-41A3-9743-147C16EC2117Q37104415-F1824698-8752-4AEA-97AA-3517A75AE9B1Q37128042-349BE838-120B-49FA-A54A-F1FABA499C03Q37137072-C5057331-5248-4DCA-B84E-4425EB52B5D7Q37450284-6FCC3234-81B7-48D6-BCBF-DDF8C8D4E9DFQ37559823-1E24B59F-6F10-4196-A976-5B2C24FE7D86Q37710849-1366BF3D-478E-4645-9E96-FF946A042D0BQ37878247-81F0A0EB-A91A-45EF-B833-2641802DD3DEQ38496459-90EF5968-0EE6-4417-B714-DD2C10EFB8CDQ40197087-926FA4EF-92E4-46CA-B6D7-0C10DFFB5548Q41474658-FA72DC9E-2AC7-4B5D-8FD5-1188ECCC9E2C
P2860
Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Metabolic changes within the l ...... resistant unipolar depression.
@en
Metabolic changes within the l ...... resistant unipolar depression.
@nl
type
label
Metabolic changes within the l ...... resistant unipolar depression.
@en
Metabolic changes within the l ...... resistant unipolar depression.
@nl
prefLabel
Metabolic changes within the l ...... resistant unipolar depression.
@en
Metabolic changes within the l ...... resistant unipolar depression.
@nl
P2093
P1476
Metabolic changes within the l ...... resistant unipolar depression.
@en
P2093
P304
P356
10.1017/S0033291703007931
P407
P577
2003-10-01T00:00:00Z